NCT03176706

Brief Summary

To avoid iodine deficiency and its consequences in pregnant women and their offspring, women should reach a sufficient iodine intake long before conception. To monitor iodine status, median urinary iodine concentration (UIC) is widely used in pregnant women (PW). Thyroglobulin (Tg) us another marker used to assess iodine status . In this study, urine samples as well as dried blood spots will be collected to measure UIC and Tg (as well as other hormones to define thyroid function) in PW. The results shall be used to reassess the threshold which defines iodine status in PW according to UIC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 5, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

August 9, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2019

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

2.1 years

First QC Date

June 2, 2017

Last Update Submit

May 11, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urinary iodine concentration and Thyroglobulin concentration in pregnant women.

    Analysis of urine and blood samples to find urinary iodine concentration and Thyroglobulin concentration of each participant.

    June 2018

Study Arms (7)

Lebanese pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in the Lebanon.

Other: no intervention

Thai pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in Thailand.

Other: no intervention

South African pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in South Africa.

Other: no intervention

New Zealand pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in New Zealand.

Other: no intervention

Swedish Pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in Sweden.

Other: no intervention

Peruvian pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in Peru.

Other: no intervention

Russian pregnant women

Pregnant women which are suspected to have mild to moderate iodine deficiency but are otherwise health and living in Russia.

Other: no intervention

Interventions

this is a completely observational study, NO INTERVENTION

Lebanese pregnant womenNew Zealand pregnant womenPeruvian pregnant womenRussian pregnant womenSouth African pregnant womenSwedish Pregnant womenThai pregnant women

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy pregnant women aged from 18 to 44 years, living since 12 months or longer in the respective country.

You may qualify if:

  • Generally healthy
  • No major medical illness, no thyroid disease, and taking no chronic medication
  • No use of iodine containing dietary supplements
  • No use of iodine-containing X-ray /CT contrast agent or iodine containing medication within the last year
  • Aged between 18 and 44 at enrollment
  • Singleton pregnancy
  • Non-smoking
  • Residence at study site since 12 months or longer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Otago

Dunedin, Otago, 9054, New Zealand

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

June 2, 2017

First Posted

June 5, 2017

Study Start

August 9, 2017

Primary Completion

August 31, 2019

Study Completion

August 31, 2019

Last Updated

May 13, 2020

Record last verified: 2020-05

Locations